FDA recall D-1149-2023

VistaPharm LLC · Class II · drug

Product

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

Reason for recall

Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

Distribution

Distributed nationwide to 68 consignees in the U.S.

Key facts

Status
Terminated
Initiation date
2023-08-30
Report date
2023-09-20
Termination date
2024-07-26
Voluntary/Mandated
Voluntary: Firm initiated
Location
Largo, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1149-2023